The Indian government is doling out ₹1500 crore to reserve 300 million of Biological-E’s COVID-19 vaccine doses
- The Indian government is booking 300 million doses of
Biological-E’s COVID-19 vaccinein advance in the face of a massive shortage.
- Biological-E’s candidate will be the second ‘made-in-India’ vaccine to hit the market after
- The government is shelling out a massive ₹1500 crore to secure the doses.
AdvertisementIn a bid to meet the increasing demand for the Coronavirus vaccine, the Indian government is shelling out ₹1,500 crore to secure 300 million doses of Biological-E’s
The price of Biological-E’s vaccine is not publicly known, but according to the company, it is aiming to be one of the ‘ most affordable’ options in the country.
This will be the second domestically developed vaccine to hit the market, once approved, after Bharat Biotech’s Covaxin. The vaccine candidate, which is modelled after the Hepatitis E vaccine, is currently undergoing Phase III of its clinical trials.
“The proposal of M/s Biological-E was examined and recommended for approval after due diligence by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC),” said the
Biological-E is developing the vaccine in association with the Baylor College of Medicine in the US and already has two agreements in place to manufacture the vaccine in India — one with Canada-based Providence Therapeutics Holdings and another with Johnson & Johnson.
Bharat Biotech and the
According to India’s Ministry of Health and Family Welfare (MoHFW), the Hyderabad-based pharmaceutical company will start manufacturing and stockpiling doses somewhere between August and December 2021.
Huawei announces first devices with HarmonyOS — set to take on Apple and Google with its in-house operating system
OnePlus Nord CE 5G full specifications leaked days ahead of launch – heavily inspired by the original Nord
Popular on BI
- IAF to induct first batch of indigenously-developed light combat vehicles on Monday
- Infosys to lead IT sector’s Q2 show with 4% revenue growth, says Jefferies
- IISC joins hands with AIIMS Rishikesh to develop algorithm that can read brain scans to detect epilepsy
- Overlapping symptoms of dengue, Covid-19 confusing in many cases, say doctors
- Sterlite Technologies launches optical solution for 5G rollout